Avita Logo.png
AVITA Medical® to Present at the Piper Sandler 34th Annual Healthcare Conference
November 21, 2022 16:01 ET | AVITA Medical
VALENCIA, Calif., and MELBOURNE, Australia, Nov. 21, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and...
Avita Logo.png
AVITA Medical® to Host Investor Webinar Briefing
November 16, 2022 21:00 ET | AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, Nov. 16, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and...
Avita Logo.png
AVITA Medical Reports Third Quarter 2022 Financial Results
November 10, 2022 16:01 ET | AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, Nov. 10, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and...
Avita Logo.png
AVITA Medical Announces Achievement of Co-Primary Endpoints in Updated Analysis of Pivotal Trial of RECELL® System for Soft Tissue Repair
November 09, 2022 18:45 ET | AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, Nov. 09, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and...
Avita Logo.png
AVITA Medical Announces FDA Breakthrough Device Designations for the RECELL® System
November 03, 2022 20:15 ET | AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, Nov. 03, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and...
Avita Logo.png
AVITA Medical to Announce Third Quarter 2022 Financial Results
October 20, 2022 16:01 ET | AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, Oct. 20, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and...
Avita Logo.png
AVITA Medical Appoints Industry Leader James Corbett as Chief Executive Officer
September 28, 2022 19:06 ET | AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, Sept. 28, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and...
Avita Logo.png
Investor Webinar Briefing
September 13, 2022 16:11 ET | AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, Sept. 13, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and...
Avita Logo.png
AVITA Medical Achieves Positive Topline Pivotal Trial Results for Treatment of Stable Vitiligo Using the RECELL® System
September 12, 2022 16:23 ET | AVITA Medical
The study achieved its primary effectiveness endpoint of super-superiority AVITA Medical continues to plan for submission to FDA by the end of 2022 VALENCIA, Calif. and MELBOURNE, Australia, Sept. ...
Avita Logo.png
RECELL System Insurance Coverage Begins in Japan for Treatment of Acute Burns
September 01, 2022 08:00 ET | AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, Sept. 01, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and...